Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Nakagama

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Cancer Letters|December 13, 2005
Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide, a carcinogen producing bulky adductsAkemi Gunji, Akiko Uemura, Masahiro Tsutsumi, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|May 12, 2020
Comprehensive analysis of DNA adducts (DNA adductome analysis) in the liver of rats treated with 1,4-dioxaneYukari Totsuka, Yuya Maesako, Hanako Ono, et al.
Journal of Cell Science|August 3, 2011
SCFβ(TrCP) mediates stress-activated MAPK-induced Cdc25B degradationSanae Uchida, Nobumoto Watanabe, Yasusei Kudo, et al.
Cancer Research|May 17, 2014
A rare polymorphic variant of NBS1 reduces DNA repair activity and elevates chromosomal instabilityYuki Yamamoto, Mamiko Miyamoto, Daisuke Tatsuda, et al.
BMC Genomics|February 9, 2007
Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cellsHideki Ogino, Tadashige Nozaki, Akemi Gunji, et al.
Toxicology Reports|October 1, 2017
A novel aromatic mutagen, 5-amino-6-hydroxy-8<i>H</i>-benzo[6,7]azepino[5,4,3-<i>de</i>]quinolin-7-one (ABAQ), induces colonic preneoplastic lesions in miceTakahiro Kochi, Masahito Shimizu, Yukari Totsuka, et al.
Oncogene|December 21, 2004
Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agentAtsushi Shibata, Nobuo Kamada, Ken-Ichi Masumura, et al.
PPAR Research|September 4, 2010
PPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot StudyHirokazu Takahashi, Kunihiro Hosono, Takashi Uchiyama, et al.
The Journal of Biological Chemistry|July 25, 2009
Translesional DNA synthesis through a C8-guanyl adduct of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Vitro: REV1 inserts dC opposite the lesion, and DNA polymerase kappa potentially catalyzes extension reaction from the 3'-dC terminusHirokazu Fukuda, Takeji Takamura-Enya, Yuji Masuda, et al.
International Journal of Cancer|August 18, 2010
NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)Rong Wang, Wan-Mohaiza Dashwood, Hui Nian, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Cancer Letters|December 13, 2005
Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide, a carcinogen producing bulky adductsAkemi Gunji, Akiko Uemura, Masahiro Tsutsumi, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|May 12, 2020
Comprehensive analysis of DNA adducts (DNA adductome analysis) in the liver of rats treated with 1,4-dioxaneYukari Totsuka, Yuya Maesako, Hanako Ono, et al.
Journal of Cell Science|August 3, 2011
SCFβ(TrCP) mediates stress-activated MAPK-induced Cdc25B degradationSanae Uchida, Nobumoto Watanabe, Yasusei Kudo, et al.
Cancer Research|May 17, 2014
A rare polymorphic variant of NBS1 reduces DNA repair activity and elevates chromosomal instabilityYuki Yamamoto, Mamiko Miyamoto, Daisuke Tatsuda, et al.
BMC Genomics|February 9, 2007
Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cellsHideki Ogino, Tadashige Nozaki, Akemi Gunji, et al.
Toxicology Reports|October 1, 2017
A novel aromatic mutagen, 5-amino-6-hydroxy-8<i>H</i>-benzo[6,7]azepino[5,4,3-<i>de</i>]quinolin-7-one (ABAQ), induces colonic preneoplastic lesions in miceTakahiro Kochi, Masahito Shimizu, Yukari Totsuka, et al.
Oncogene|December 21, 2004
Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agentAtsushi Shibata, Nobuo Kamada, Ken-Ichi Masumura, et al.
PPAR Research|September 4, 2010
PPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot StudyHirokazu Takahashi, Kunihiro Hosono, Takashi Uchiyama, et al.
The Journal of Biological Chemistry|July 25, 2009
Translesional DNA synthesis through a C8-guanyl adduct of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Vitro: REV1 inserts dC opposite the lesion, and DNA polymerase kappa potentially catalyzes extension reaction from the 3'-dC terminusHirokazu Fukuda, Takeji Takamura-Enya, Yuji Masuda, et al.
International Journal of Cancer|August 18, 2010
NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)Rong Wang, Wan-Mohaiza Dashwood, Hui Nian, et al.
Pageof 18